A Reversal on Sequencing? Proposed Legislation Would Allow Patenting of Naturally Occurring Genes
FDA Law Blog
OCTOBER 24, 2024
Rather, developers of diagnostic tests and, indeed of any product that relies on free access to gene sequence and other biomarker information, should pay also close attention, as PERA would overturn longstanding judicial precedent. By 2010, about 2000 isolated human genes had been patented in the U.S.
Let's personalize your content